|
Nov 29
|
Gilead to lay off staff at cell therapy unit Kite
|
|
Nov 28
|
AWS expands big pharma partnerships in manufacturing, AI, and R&D
|
|
Nov 28
|
Gilead's Ambition: To Help End the HIV Epidemic
|
|
Nov 26
|
3 Fantastic Dividend Stocks to Buy Sooner Rather Than Later
|
|
Nov 26
|
15 Best Drug Stocks To Invest In
|
|
Nov 24
|
Zacks Industry Outlook Highlights Gilead Sciences, CRISPR Therapeutics, ACADIA Pharmaceuticals, Dynavax and Ligand Pharmaceuticals
|
|
Nov 15
|
ARCELLX AND KITE ANNOUNCE EXPANSION IN STRATEGIC PARTNERSHIP
|
|
Nov 15
|
Kite and Arcellx Announce Expansion in Strategic Partnership
|
|
Nov 14
|
Jim Simons Stock Portfolio: 12 Biggest Healthcare Stocks
|
|
Nov 10
|
Gilead Sciences (NASDAQ:GILD) shareholders YoY returns are lagging the company's 19% three-year earnings growth
|
|
Nov 9
|
Gilead Sciences: Research Scholars Program Scientists Advancing HIV Research
|
|
Nov 9
|
Top 20 Drug Companies in the US by Revenue
|
|
Nov 9
|
Gilead Sciences to Present at Upcoming Investor Conferences
|
|
Nov 8
|
Gilead Tumbles After An Unpredictable Element Drove Its Third-Quarter Beat
|
|
Nov 8
|
Gilead Sciences, Inc. (NASDAQ:GILD) Q3 2023 Earnings Call Transcript
|
|
Nov 8
|
Gilead (GILD) Q3 Earnings Beat, Trodelvy Fuels Oncology Sales
|
|
Nov 8
|
Midday movers: Warner Bros Discovery, Eli Lilly, Robinhood and more
|
|
Nov 8
|
Q3 2023 Gilead Sciences Inc Earnings Call
|
|
Nov 8
|
Gilead reports better-than-expected earnings amid strong cancer drug sales
|
|
Nov 8
|
The Gilead Sciences Inc (GILD) Company: A Short SWOT Analysis
|